Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 12, Issue 1, Pages 19-25
http://dx.doi.org/10.1155/2005/612387
Original Article

Cost Effectiveness of Positron Emission Tomography for the Management of Potentially Operable Non-Small Cell Lung Cancer in Quebec

Van Hung Nguyen,1 Serge Péloquin,2 and Yves Lacasse3

1Agence d’évaluation des technologies et des modes d’intervention en santé, Montreal, Canada
2Départment du développement et d’évaluation des technologies, Ministère de la santé et services sociaux, Quebec City, Canada
3Centre de recherche, Centre de pneumologie, Hôpital Laval, Institut universitaire de cardiologie et de pneumologie de l’Université Laval, Ste-Foy, Quebec, Canada

Copyright © 2005 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • S. Marnitz, P. Messer, M. Stuschke, C. Pöttgen, and W. Hinkelbein, “Einsatz der PET-CT zur Verbesserung der Bestrahlungsplanung nichtkleinzelliger Bronchialkarzinome,” Der Onkologe, vol. 11, no. 8, pp. 859–865, 2005. View at Publisher · View at Google Scholar
  • Vaylet, Bonardel, Salles, Bonnichon, Gontier, Foehrenbach, Margery, Mantzarides, and Guigay, “PET scanning in the initial assessment of lung cancer,” Revue des Maladies Respiratoires, vol. 22, no. 6, pp. S43–S48, 2005. View at Publisher · View at Google Scholar
  • Gontier, Mairovitz, Niang, Vaylet, Marotel, Foehrenbach, Bonnichon, Salles, Bonardel, Lefloch, and Mantzarides, “Fluorodeoxyglucose F-18 positron emission tomography (18FDG-PET) in the management of non small cell lung cancer in 2006,” Cancer/Radiotherapie, vol. 11, no. 1-2, pp. 16–22, 2007. View at Publisher · View at Google Scholar
  • Raphaël Remonnay, Magali Morelle, Pascal Pommier, Francesco Giammarile, and Marie-Odile Carrère, “Assessing short-term effects and costs at an early stage of innovation: The use of positron emission tomography on radiotherapy treatment decision making,” International Journal of Technology Assessment in Health Care, vol. 24, no. 02, 2008. View at Publisher · View at Google Scholar
  • June Corry, Danny Rischin, Rodney J. Hicks, and Lester J. Peters, “The role of PET-CT in the management of patients with advanced cancer of the head and neck,” Current Oncology Reports, vol. 10, no. 2, pp. 149–155, 2008. View at Publisher · View at Google Scholar
  • Joseph T Wee, Benjamin O Anderson, June Corry, Anil D'Cruz, Khee C Soo, Chao-Nan Qian, Daniel T Chua, Rodney J Hicks, Christopher HK Goh, James B Khoo, Seng C Ong, Arlene A Forastiere, and Anthony T Chan, “Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009,” The Lancet Oncology, vol. 10, no. 11, pp. 1086–1092, 2009. View at Publisher · View at Google Scholar
  • F. Vaylet, F. Rivière, H. Le Floch, M. Billhot, J. Margery, G. Bonardel, A. Mairovitz, C. Marotel, and H. Foehrenbach, “Bilan d’extension du cancer bronchique par la tomographie à émission de positons au 18-fluorodéoxyglucose (FDG-TEP),” Revue des Maladies Respiratoires Actualités, vol. 2, no. 3, pp. 212–220, 2010. View at Publisher · View at Google Scholar
  • F. Vaylet, J. Margery, G. Bonardel, H. Le Floch, F. Rivière, E. Gontier, I. Ngampolo, A. Mairovitz, C. Marotel, and H. Foehrenbach, “Quelle place en oncologie thoracique pour la tomographie par émission de positons au 18FDG (TEP-FDG) en 2010 ?,” Revue de Pneumologie Clinique, vol. 66, no. 4, pp. 221–238, 2010. View at Publisher · View at Google Scholar
  • A. Langer, “Kosteneffektivität diagnostischer Verfahren,” Der Onkologe, vol. 16, no. 10, pp. 992–1002, 2010. View at Publisher · View at Google Scholar
  • Astrid Langer, “A systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?,” BMC Health Services Research, vol. 10, no. 1, 2010. View at Publisher · View at Google Scholar
  • G. Bonardel, E. Gontier, M. Soret, P. Maszelin, C. Dechaud, F. Vaylet, and H. Foehrenbach, “Tomographie par émission de positons en pathologie tumorale thoracique,” EMC - Radiologie et imagerie médicale - Cardiovasculaire - Thoracique - Cervicale, vol. 5, no. 2, pp. 1–24, 2010. View at Publisher · View at Google Scholar
  • Goeckenjan, Ficker, Lübbe, Reinhold, Späth-Schwalbe, Ukena, Wickert, Wolf, Andreas, Baysal, Beuth, Bickeböller, Bohle, Brüske, Burghuber, Dickgreber, Eggeling, Fink, Gauler, Gütz, Herth, Heußel, Hilbe, Hoffmeyer, Huber, Kirsten, Lang, Griesinger, Ochmann, Passlick, Petersen, Schmittel, Schönfeld, Niederle, Schütte, Serke, Steingräber, Steins, Swoboda, Tessen, Weber, Stuschke, Wichmann, Irlinger Wimmer, Worth, Blum, Deppermann, Freitag, Sitter, Auberger, Baum, Böcking, Thomas, Diederich, Dienemann, Eberhardt, Fischer, Franke, Friedel, Branscheid, Hautmann, Hellmann, Hellwig, Horneber, Hübner, Flentje, Kauczor, Kirchbacher, Kraus, Martens, Mohn-Staudner, Müller, Müller-Nordhorn, Nowak, Pirker, Pokrajac, Reck, Riha, Rübe, Stamatis, Stoelben, Teschler, Werner, and Witt, “Prevention, diagnosis, therapy, and follow-up of lung cancer,” Pneumologie, vol. 64, no. 2, pp. e1–e164, 2010. View at Publisher · View at Google Scholar
  • Richard P. Baum, Cyprian Świȩtaszczyk, and Vikas Prasad, “FDG-PET/CT in lung cancer: An update,” Frontiers of Radiation Therapy and Oncology, vol. 42, pp. 15–45, 2010. View at Publisher · View at Google Scholar
  • Rikke Søgaard, Barbara Malene B. Fischer, Jann Mortensen, Liselotte Højgaard, and Ulrik Lassen, “Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 5, pp. 802–809, 2011. View at Publisher · View at Google Scholar
  • Jeffrey Q. Cao, George B. Rodrigues, Alexander V. Louie, and Gregory S. Zaric, “Systematic Review of the Cost-Effectiveness of Positron-Emission Tomography in Staging of Non–Small-Cell Lung Cancer and Management of Solitary Pulmonary Nodules,” Clinical Lung Cancer, vol. 13, no. 3, pp. 161–170, 2012. View at Publisher · View at Google Scholar
  • Barbara M. Fischer, and Jann Mortensen, “The role of positron emission tomography for evaluation of lung nodules and staging lung cancer,” Current Respiratory Care Reports, vol. 1, no. 1, pp. 30–39, 2012. View at Publisher · View at Google Scholar
  • Joon Young Choipp. 355–372, 2013. View at Publisher · View at Google Scholar
  • John Buscombe, and E O’Rourke, “ Is 18 F FDG PET-CT cost effective in lung cancer? ,” Expert Review of Anticancer Therapy, vol. 7, no. 4, pp. 471–476, 2014. View at Publisher · View at Google Scholar
  • Salvatore Annunziata, “Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review,” World Journal of Radiology, vol. 6, no. 3, pp. 48, 2014. View at Publisher · View at Google Scholar
  • Florian C. Gärtner, Markus Essler, Jens Buermann, Dirk Skowasch, and Hans-Jürgen Biersack, “The role of PET in lung cancer staging,” Deutsche Medizinische Wochenschrift, vol. 140, no. 9, pp. 679–683, 2015. View at Publisher · View at Google Scholar
  • Oke Gerke, Ronnie Hermansson, Søren Hess, Søren Schifter, Werner Vach, and Poul Flemming Høilund-Carlsen, “Cost-effectiveness of PET and PET/Computed Tomography,” PET Clinics, vol. 10, no. 1, pp. 105–124, 2015. View at Publisher · View at Google Scholar
  • Aline Navega Biz, and Rosângela Caetano, “Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers,” Revista de Saúde Pública, vol. 49, no. 0, pp. 1–10, 2015. View at Publisher · View at Google Scholar